SEPARATION OF VX, RVX, AND GB ENANTIOMERS USING LIQUID CHROMATOGRAPHY TIME-OF-FLIGHT MASS SPECTROMETRY

Similar documents
CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

MEDIAN LETHAL DOSES ASSOCIATED WITH INTRAVENOUS EXPOSURE TO THE OPTICALLY PURE ENANTIOMERS OF VX IN GUINEA PIGS

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

Fort Detrick, Maryland

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

INTENSITY REDISTRIBUTION FOR MILTICONJUGATE ADAPTIVE OPTICS (Postprint)

Award Number: W81XWH

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

Detection of Prostate Cancer Progression by Serum DNA Integrity

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Approved for public release; distribution unlimited

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Final Performance Report. Contract # FA C-0006: Hearing Protection for High-Noise Environments Period of Performance: Oct 01, 2007 Nov 30, 2009

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Effect of COX-2 (PGE2) and IL-6 on Prostate Cancer Bone Mets

Award Number: W81XWH

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

TITLE: A PSCA Promoter Based Avian Retroviral Transgene Model of Normal and Malignant Prostate

ENZYMATIC ANALYSIS OF G- AND V-AGENTS AND THEIR DEGRADATION PRODUCTS

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS

Vitamin D3 and Vitamin D3 Analogs as Protectants Against the Cardiotoxicity of Chemotherapeutic Agents Utilized in the Treatment of Breast Cancer

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

2010 Annual report. Principle Investigator: Dr. John W. Frost. Draths Corporation. ONR Award Number: N

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Approved for public release; distribution unlimited

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

Methodology for Dynamic Characterization of Fragmenting Warheads

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

The Impact of Emerging Infectious Diseases on Military Operations

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

TITLE: Breast Tumor-Generated Type 1 Collagen Breakdown Fragments Act as Matrikines to Drive Osteolysis

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

TITLE: Interchromosomal Associations that Alter NF1 Gene Expression Can Modify Clinical Manifestations of Neurofibromatosis 1. Palo Alto, CA 94304

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

TITLE: Selective Oncolytic Therapy for Hypoxic Breast Cancer Cells. CONTRACTING ORGANIZATION: Ordway Research Institute Albany, New York 12208

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

CONTRACTING ORGANIZATION: Southern Illinois University School of Medicine, Springfield, IL

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TRANSLATION OF TOXICITY DATA INTO CW AGENT TOXICITY ESTIMATES

TITLE: Induction of Ephs/Ephrins-Mediated Tumor Cells-Endothelial Cells Repulsion as an Anti-Cancer Therapeutic Approach

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

Award Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

Utility of respiratory vaccination with recombinant subunit vaccines for protection against pneumonic plague.

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

Transcription:

ECBC-TR-1341 SEPARATION OF VX, RVX, AND GB ENANTIOMERS USING LIQUID CHROMATOGRAPHY TIME-OF-FLIGHT MASS SPECTROMETRY Sue Y. Bae Mark D. Winemiller RESEARCH AND TECHNOLOGY DIRECTORATE February 2016 Approved for public release; distribution is unlimited.

Disclaimer The findings in this report are not to be construed as an official Department of the Army position unless so designated by other authorizing documents.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 h per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) XX-02-2016 2. REPORT TYPE Final 4. TITLE AND SUBTITLE Separation of VX, RVX, and GB Enantiomers Using Liquid Chromatography Time-of-Flight Mass Spectrometry 3. DATES COVERED (From - To) Mar 2015 Aug 2015 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Bae, Sue Y.; and Winemiller, Mark D. 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) Director, ECBC, ATTN: RDCB-DRC-C, APG, MD 21010-5424 8. PERFORMING ORGANIZATION REPORT NUMBER ECBC-TR-1341 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for public release; distribution is unlimited. 13. SUPPLEMENTARY NOTES 14. ABSTRACT: Chemical nerve agents such as VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate), RVX (S-[2-(diethylamino)ethyl] O-isobutyl-methylphosphonothioate), and GB (isopropyl methylphosphonofluoridate) exist as a mixture of two enantiomers. A Lux 5u Cellulose-1 normal-phase chiral liquid chromatography column (Phenomenex; Torrance, CA) was used to separate the enantiomers for all V and G agents within 15 min. Atmospheric pressure chemical ionization mode was used for liquid chromatography time-of-flight mass spectrometry analysis. For large-scale separation and quantitation, the UV absorbance at 210 nm (with a bandwidth of 4 nm) was referenced to a wavelength of 360 nm. An Agilent series 1200 fraction collector (Agilent Technologies; Santa Clara, CA) was used to collect both (+) and ( ) enantiomers for each chemical agent separated. Identification and isolation of each enantiomer of a chemical agent is very beneficial for in vitro and in vivo toxicological studies. 15. SUBJECT TERMS O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate (VX) S-[2-(diethylamino)ethyl] O-isobutyl-methylphosphonothioate (RVX) Isopropyl methylphosphonofluoridate (GB, sarin) UV chromatography Enantiomers 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 18. NUMBER OF PAGES 20 19a. NAME OF RESPONSIBLE PERSON Renu B. Rastogi 19b. TELEPHONE NUMBER (include area code) (410) 436-7545 Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

Blank ii

PREFACE This work was started in March 2015 and completed in August 2015. The use of either trade or manufacturers names in this report does not constitute an official endorsement of any commercial products. This report may not be cited for purposes of advertisement. This report has been approved for public release. iii

Blank iv

CONTENTS 1. INTRODUCTION...1 2. EXPERIMENTAL METHODS...2 2.1 Reagents and Chemicals...2 2.2 Instrumentation...2 3. RESULTS AND DISCUSSION...2 4. CONCLUSION...6 LITERATURE CITED...7 ACRONYMS AND ABBREVIATIONS...9 v

FIGURES 1. Chemical structures of three chemical warfare agents...1 2. A representative TIC and mass spectrum for VX enantiomers...3 3. A representative UV chromatogram of VX enantiomers...3 4. A representative TIC and mass spectrum for RVX enantiomers...4 5. A representative UV chromatogram of RVX enantiomers...5 6. A representative TIC and mass spectrum for GB enantiomers...6 vi

SEPARATION OF VX, RVX, AND GB ENANTIOMERS USING LIQUID CHROMATOGRAPHY TIME-OF-FLIGHT MASS SPECTROMETRY 1. INTRODUCTION Tetra-coordinate pentavalent phosphorus compounds have four bonds arranged through sp 3 hybrid orbitals as occurs in tetrahedral carbon compounds. The first enantiomeric phosphorus compound, ethylmethylphenylphosphine oxide, or Et(Me)P(O)Ph, was isolated in 1911 by J. Meisenheimer and L. Lichtenstadt. 1 Many organophosphorus (OP) pesticides have an asymmetric phosphorus atom, and several have been separated into individual enantiomers. 2 OP nerve agents such as O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate (VX) have an asymmetric phosphorus atom, and synthesis of VX yields a racemic mix of two enantiomers, P(+) and P( ). Although the enantiomers have identical physical properties, their biological activities depend greatly on their chirality. Compared with the P(+) enantiomer, the P( ) enantiomer has an order of magnitude higher effect on the rate of inhibition of acetylcholinesterase, which lowers the LD50 (the dose that is lethal to 50% of test subjects) in mice. 3,4 The literature is limited regarding the use of chromatographic techniques to separate the enantiomers of chemical warfare agents. 5 7 Although reports exist of VX being separated, the enantiomer separation took longer than 65 min with use of liquid chromatography (LC) and tandem mass spectrometry, and more than 5 h with use of gas chromatography and mass spectrometry (MS). Only one report, by J. Smith, described a baseline-resolved separation of the VX enantiomers in less than 10 min. 8 This was accomplished using a Chiralcel OD-H column (Daicel Corporation; Osaka-Shi, Japan). We now report the development of an analytical method for separating the enantiomers of nerve agents VX, S-(2-(diethylamino)ethyl) O-isobutyl-methylphosphonothioate (RVX), and isopropyl methylphosphonofluoridate (GB) (Figure 1) using a normal-phase chiral LC column and atmospheric pressure chemical ionization mass spectrometry (APCI MS). This separation was then transferred to a preparative-scale instrument, and a UV detection source was used to collect the individual P(+) and P( ) enantiomers of the desired agents. Figure 1. Chemical structures of three chemical warfare agents. 1

2. EXPERIMENTAL METHODS 2.1 Reagents and Chemicals Nerve agents VX, RVX, and GB, all of which were of >95% purity, were synthesized by the Agent Chemistry Team from the Research and Technology Directorate of the U.S. Army Edgewood Chemical Biological Center (Aberdeen Proving Ground, MD). Samples were made at a 100 µg/ml level for analytical separation and a 22 mg/ml level for preparative separation. All reagents and solvents were high-performance LC grade. Hexane and isopropyl alcohol were purchased from Fisher Scientific (Waltham, MA). 2.2 Instrumentation The analytical separations of the enantiomers were characterized using an Agilent 1200 Infinity series LC system (Agilent Technologies; Santa Clara, CA), and APCI MS was performed on a Lux Cellulose-1 column (250 4.6 mm, 5 µm; Phenomenex; Torrance, CA). The mobile phase consisted of n-hexane (A) and isopropyl alcohol (B), and sample volume was 10 µl. Separation was achieved using isocratic conditions of 96/4 (v/v %) A/B for VX and RVX and 95/5 (v/v %) A/B for GB, with a flow rate of 0.6 ml/min. The enantioselective preparative-scale separation of agents was achieved using an Agilent 1100 series preparative-scale LC system equipped with a diode array detector. Injections were monitored at 210 nm. Separation was achieved using a Phenomenex Lux Cellulose-1 Axia packed column (250 30 mm) with an isocratic condition of 96/4 (v/v %) A/B, a flow rate of 20 ml/min, and a sample volume of 1000 µl. Both VX enantiomers were baseline separated within 23 min. The Agilent 1200 Infinity series fraction collector was configured using the peaktime-based collection protocol, and the separated enantiomers were combined into 500 ml round-bottom flasks for solvent removal by rotary evaporation. Individual enantiomers were confirmed by polarimetry using a Vee Gee polarimeter (Vee Gee Scientific; Kirkland, WA) and a 10 ml optical cell. 3. RESULTS AND DISCUSSION For the LC MS analytical analysis, the MS system was operated in total ion chromatogram (TIC) mode at m/z 50 500 for VX, RVX, and GB. APCI mode was used for LC time-of-flight MS. A Lux 5u Cellulose-1 column and normal-phase LC were used with a mobile phase of 96/4 (v/v %) hexane/isopropyl alcohol at a flow rate of 0.6 ml/min. The enantiomers were baseline-resolved within 15 min. The analytical separation method was then transferred to the preparative-scale LC for large-scale isolation of the desired enantiomers. As shown in Figure 2, the VX enantiomers eluted at 9.5 and 11.3 min when the fragmentor voltage was 100 V. As expected, the mass spectrum for the enantiomer at 9.5 min was identical to that for the enantiomer at 11.3 min. A UV detector was incorporated in the analytical analysis to monitor for the appearance of VX. The observation wavelength was 210 nm using a bandwidth of 2 nm, and the reference wavelength was 300 nm. The analytical 2

separation method was successfully transferred to the preparative-scale system using a Phenomenex Lux Cellulose-1 Axia packed column. The fraction collector was set as time-based, and fractions were collected into multiple test tubes from 13 to 17.5 min for the P(+) enantiomer and from 18 to 23.5 min for the P( ) enantiomer (Figure 3). Figure 2. A representative TIC and mass spectrum for VX enantiomers. Figure 3. A representative UV chromatogram of VX enantiomers. 3

When a fragmentor voltage of 100 V was used, the RVX enantiomers eluted at 10.9 and 13.2 min (Figure 4). The mass spectra of the enantiomers were again identical. For the isolation of individual enantiomers, the preparative-scale separation method was the same as that used for VX. A representative UV chromatogram of the RVX enantiomers is shown in Figure 5. Figure 4. A representative TIC and mass spectrum for RVX enantiomers. 4

Figure 5. A representative UV chromatogram of RVX enantiomers. For the enantioselective separation of GB, the enantiomers were baseline-resolved within 15 min using a mobile phase of 95/5 (v/v %) hexane/isopropyl alcohol at a flow rate of 0.6 ml/min. A representative TIC (Figure 6) shows that the GB enantiomers eluted at 12 and 14 min when a fragmentor voltage of 100 V was used. Examination of the mass spectra revealed two peaks, shown at retention times of 6.0 and 9.0 min, that represented impurities in the GB sample. We did not further investigate the impurities in the GB sample. The mass spectra for the GB enantiomers were identical. The mass spectrum for GB shown in Figure 6 exhibits mass ions at m/z 98.46 due to loss of a propane group and at m/z 158.19 due to [M+H2O] +. For isolation of the individual enantiomers of GB, the same preparative-scale separation method was used as for VX and RVX. 5

Figure 6. A representative TIC and mass spectrum for GB enantiomers. 4. CONCLUSION Analytical- and preparative-scale LC methods for the enantioselective separation of VX, RVX, and GB were developed. This report details the separation analysis and results of the study. The separation and isolation methods were easy to use and should be readily accessible for any laboratory. Because of the differing toxicity and acetylcholinesterase inhibition rates between the P(+) and P( ) enantiomers, identification and isolation of each enantiomer is very beneficial for in vitro and in vivo toxicological studies. 6

LITERATURE CITED 1. Meisenheimer, J.; Lichtenstadt, L. Über optisch-aktive Verbindungen des Phospors. Berichte der Deutschen Chemischen Gesellschaft 1911, 44, 356 359. 2. Timperley, C.M. Best Synthetic Methods: Organophosphorus (V) Chemistry, 1st ed.; Elsevier: London, UK, 2014; Vol. 1. 3. Hall, C.R.; Inch, T.D.; Inns, R.H.; Muir, A.W.; Sellers, D.J.; Smith, A.P. Differences between Some Biological Properties of Enantiomers of Alkyl S-Alkyl Methylphosphonothioates. J. Pharm. Pharmacol. 1977, 29, 574 576. 4. Benschop, H.P.; De Jong, L.P.A. Nerve Agent Stereoisomers: Analysis, Isolation and Toxicology. Acc. Chem. Res. 1988, 21, 368 374. 5. Reiter, G.; Mikler, J.; Hill, I.; Weatherby, K.; Thiermann, H.; Worek, F. Chromatographic Resolution, Characterisation and Quantification of VX Enantiomers in Hemolysed Swine Blood Samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 873, 86 94. 6. Van den Berg, G.R.; Beck, H.C.; Benschop, H.P. Stereochemical Analysis of the Nerve Agents Soman, Sarin, Tabun, and VX by Proton NMR-Spectroscopy with Optically Active Shift Reagents. Bull. Environ. Contam. Toxicol. 1984, 33, 505 514. 7. Smith, J.R.; Schlager, J.J. Gas Chromatographic Separation of the Stereoisomers of Organophosphorus Chemical Warfare Agents Using Cyclodextrin Capillary Columns. J. High Res. Chromatogr. 1996, 19, 151 154. 8. Smith, J.R. Analysis of the Enantiomers of VX Using Normal-Phase Chiral Liquid Chromatography with Atmospheric Pressure Chemical Ionization Mass Spectrometry. J. Anal. Toxicol. 2004, 28, 390 392. 7

Blank 8

ACRONYMS AND ABBREVIATIONS APCI Et(Me)P(O)Ph GB LC MS OP RVX TIC VX atmospheric pressure chemical ionization ethylmethylphenylphosphine oxide isopropyl methylphosphonofluoridate, sarin liquid chromatography mass spectrometry organophosphorus S-(2-(diethylamino)ethyl) O-isobutyl-methylphosphonothioate total ion chromatogram O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate 9

DISTRIBUTION LIST The following organizations were provided with one Adobe portable document format (pdf) version of this report: U.S. Army Edgewood Chemical Biological Center (ECBC) RDCB-DRC-C ATTN: Bae, S. Winemiller, M. Berg, F. ECBC Technical Library RDCB-DRB-BL ATTN: Foppiano, S. Stein, J. G-3 History Office U.S. Army RDECOM ATTN: Smart, J. Office of the Chief Counsel AMSRD-CC ATTN: Upchurch, V. Defense Technical Information Center ATTN: DTIC OA